References
- World Health Organization Statistical Information System; 2007. http://www.who.int/whosis/
- Cifkova R, Pitha J, Lejskova M, Lanska V, Zecova S. Blood pressure around the menopause: a population study. J Hypertens 2008;26:1976–82
- Gohlke-Bärwolf C. Coronary artery disease: Is menopause a risk factor?. Basic Res Cardiol 2000;95(Suppl 1):177–83
- Bonora E, Kiehl S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Brunneck Study. Diabetes Care 2003;26:1251–7
- Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and all causes in United States adults. Circulation 2004;110:1245–50
- Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404–11
- Polotsky HN, Polotsky AJ. Metabolic implications of menopause. Semin Reprod Med 2010;5:426–34
- Imke J, Lynda HP, Sybil C, Bill L, Kim ST. Menopause and metabolic syndrome. Arch Intern Med 2008;168:1568–75
- Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics. 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69–171
- Guthrie JR, Taffe JR, Lehert P, Burger HG, Dennerstein L. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause 2004;11:315–22
- Hunter MS. Emotional well being, sexual behaviour and hormone replacement. Maturitas 1990;12:349–58
- Belue R, Okonor TA, Iwelunmor J, et al. An overview of cardiovascular risk factor burden in sub-Saharan Africa: a socio-cultural perspective. Global Health 2009;5:10
- Smith SM, Menshah GA. Population aging and implication for epidemic cardiovascular disease in sub-Saharan Africa. Ethn Dis 2003;13:S77–80
- Hill K. The demography of menopause. Maturitas 1996;23:113–27
- Ogbera A, Fasanmade O, Kalra S. Menopausal symptoms and the metabolic syndrome in Nigerian women with type 2 diabetes mellitus. Climacteric 2011;14:75–82
- Arthur FK, Adu-Frimpong M, Osei-Yeboah J, Mensah FO, Owusu L. Prediction of metabolic syndrome among postmenopausal Ghanaian women using obesity and atherogenic markers. Lipids Health Dis 2012, 11:101
- Tozin RR. Contribution in the study of postmenopausal osteoporosis among Congolese women. Thesis, Kinshasa School of Medicine, University of Kinshasa, 2000
- Ngeleka MT. Menopause among Congolese women. Thesis, Kinshasa School of Medicine, University of Kinshasa, 1993
- Lepira FB, Kayembe PK, M’Buyamba-Kabangu JR, Nseka M. Metabolic syndrome using National Cholesterol Education Program-Adult Treatment Panel III among Congolese hypertensive patients. Ann Afr Med 2010;3:395–400
- Longo-Mbenza B, On'kin JB, Okwe AN, Kabangu NK, Fuele SM. Metabolic syndrome, aging, physical activity and incidence of type diabetes in general African population. Diab Vasc Dis Res 2010;7:28–39
- Cho GJ, Lee M, Park HT, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 2008;15:524–9
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL-cholesterol in plasma without use of the preparative ultracentrifugation. Clin Chem 1972;18: 499–508
- Executive Summary of the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Treatment Panel III). JAMA 2001;285:2487–97
- WHO Scientific Group on Research on the Menopause in the 1990s. WHO technical report series. Geneva: World Health Organization, 1996;866:1–106
- Eapen DJ, Kalra GL, Rifai L, Eapen CA, Merchant N, Khan BV. Raising HDL cholesterol in women. Int J Womens Health 2010; 1:181–91
- Sultan N, Sultan A, Fayez M, Baseer A. Effect of menopause on serum HDL-c and lipids. J Ayub Metab 2003;15:24–6
- Kim CJ, Kim TH, Ryu WS, Ryoo UH. Influence of menopause on high density lipoprotein-cholesterol and lipids. J Korean Med Sci 2000;15:380–6
- Carr MC, Kim KH, Zambon A, et al. Changes in LDL density across the menopausal transition. J Investig Med 2000;48: 245–50
- Ainy E, Mirmiran P, Zahedi Asl S, Azizi F. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). Maturitas 2007;58:150–5
- Soutelo J, Saban M, Quevedo V, et al. Metabolic syndrome in Argentine women: ATP III, IDF/AHA/NHLBI; what criterion should be used?. Gynecol Endocrinol 2011;27: 448–51
- Heidari R, Sadeghi M, Talaei M, Rabiei K, Mohammadifard N, Sarrafzadegan N.Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population-based study. Diabetol Metab Syndr 2010;2:59
- Mesch VR, Boero LE, Siseles NO, et al. Metabolic syndrome throughout the menopausal transition. Influence of age and menopausal status. Climacteric 2006;9:40–8
- Figueiredo Neto JA, Figueredo ED, Barbosa JB, et al. Metabolic syndrome and menopause: cross-sectional study in gynecology. Arq Bras Cardiol 2010;95:339–45
- Indhavivadhana S, Rattanachaiyanont M, Wongvananurak T, et al. Predictors for metabolic syndrome in perimenopausal and postmenopausal Thai women. Climacteric 2011;14:58–65
- Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas 2010;65:262–6
- Appt SE, Ethun KF. Reproductive aging and risk for chronic disease: insights from studies of non human primates. Maturitas 2010;67:7–14
- Sakurai T, Iimuro S, Araki A, et al. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus. Gerontology 2010;56:141–9
- Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 2007;4:S162–77
- Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or the menopausal transition?. J Am Coll Cardiol 2009;54:2366–73
- Atwood CS, Bowen RL. The reproductive-cell cycle theory of aging: An update. Exp Gerontol 2011;46:100–7
- Santen RJ, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 95(7 Suppl 1):s1–66
- Nilsen J, Morales A, Brinton RD. Medroxyprogesterone acetate exacerbates glutamate excitotoxicity. Gynecol Endocrinol 2006; 22:355–61
- Lejskova M, Alusik S, Suchanek M, Zecova S, Pitha J. Menopause: clustering of metabolic syndrome components and population changes in insulin resistance. Climacteric 2011;14:83–91
- Nuzzo A, Rossi R, Modena MG. Hypertension alone or related to metabolic syndrome in postmenopausal women. Expert Cardiovasc Ther 2010;8:1541–8
- Bozkurt B. Where do we currently stand with advice on HRT for women. Methodist Debakey Cardiovasc J 2010;6:21–5
- Kim HM, Park J, Ryu SY, Kim J. The effect of menopause on the metabolic syndrome among Korean women. Diabetes Care 2007;30:701–6
- Ruan X, Jin J, Hua L, et al. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it. Menopause 2010;17:566–70
- Teede HJ, Lombart C, Deeks AA. Obesity, metabolic complications and menopause: an opportunity for prevention. Climacteric 2010;13:203–9
- Sumaili EK, Krzesinski JM, Ohen EP, et al. Epidemiology of chronic kidney disease in the Democratic Republic of Congo: Review of cross-sectional studies from Kinshasa, the capital of the Democratic Republic of the Congo. Nephrologie et Therapeutique 2010;6:232–9
- Cooper GS, Baird DD, Darden FR. Measures of menstrual status in relation to demographic, reproductive, and behavioral characteristics in a population-based study of women aged 35–49 years. Am J Epidemiol 2001;153:1159–65